FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309305904> ?p ?o ?g. }

• W4309305904 endingPage "435" @default.
• W4309305904 startingPage "422" @default.
• W4309305904 abstract "Novel drugs are needed to increase treatment response in children with high-risk T-cell acute lymphoblastic leukemia (T-ALL). Following up on our previous report on the activation of the MAP2K7-JNK pathway in pediatric T-ALL, here we demonstrate that OTSSP167, recently shown to inhibit MAP2K7, has antileukemic capacity in T-ALL. OTSSP167 exhibited dose-dependent cytotoxicity against a panel of T-ALL cell lines with IC50 in the nanomolar range (10-50 nM). OTSSP167 induces apoptosis and cell cycle arrest in T-ALL cell lines, associated at least partially with the inhibition of MAP2K7 kinase activity and lower activation of its downstream substrate, JNK. Other leukemic T-cell survival pathways, such as mTOR and NOTCH1 were also inhibited. Daily intraperitoneal administration of 10 mg/kg OTSSP167 was well tolerated, with mice showing no hematological toxicity, and effective at reducing the expansion of human T-ALL cells in a cell-based xenograft model. The same dosage of OTSSP167 efficiently controlled the leukemia burden in the blood, bone marrow, and spleen of 3 patient-derived xenografts, which resulted in prolonged survival. OTSSP167 exhibited synergistic interactions when combined with dexamethasone, L-asparaginase, vincristine, and etoposide. Our findings reveal novel antileukemic properties of OTSSP167 in T-ALL and support the use of OTSSP167 as an adjuvant drug to increase treatment response and reduce relapses in pediatric T-ALL." @default.
• W4309305904 created "2022-11-26" @default.
• W4309305904 creator A5009302062 @default.
• W4309305904 creator A5010578315 @default.
• W4309305904 creator A5019389611 @default.
• W4309305904 creator A5037347309 @default.
• W4309305904 creator A5082926384 @default.
• W4309305904 date "2023-02-03" @default.
• W4309305904 modified "2023-10-02" @default.
• W4309305904 title "Antileukemic properties of the kinase inhibitor OTSSP167 in T-cell acute lymphoblastic leukemia" @default.
• W4309305904 cites W1965584669 @default.
• W4309305904 cites W2000589976 @default.
• W4309305904 cites W2003013566 @default.
• W4309305904 cites W2010522003 @default.
• W4309305904 cites W2016833582 @default.
• W4309305904 cites W2022758856 @default.
• W4309305904 cites W2026951979 @default.
• W4309305904 cites W2035662710 @default.
• W4309305904 cites W2037522752 @default.
• W4309305904 cites W2038842665 @default.
• W4309305904 cites W2039616075 @default.
• W4309305904 cites W2040957529 @default.
• W4309305904 cites W2047514293 @default.
• W4309305904 cites W2053908817 @default.
• W4309305904 cites W2063953032 @default.
• W4309305904 cites W2075291089 @default.
• W4309305904 cites W2076485183 @default.
• W4309305904 cites W2077515371 @default.
• W4309305904 cites W2077945404 @default.
• W4309305904 cites W2096931514 @default.
• W4309305904 cites W2105435030 @default.
• W4309305904 cites W2115279327 @default.
• W4309305904 cites W2116254970 @default.
• W4309305904 cites W2140394521 @default.
• W4309305904 cites W2141869972 @default.
• W4309305904 cites W2154197027 @default.
• W4309305904 cites W2170444099 @default.
• W4309305904 cites W2344726805 @default.
• W4309305904 cites W2345782301 @default.
• W4309305904 cites W2553011900 @default.
• W4309305904 cites W2580215615 @default.
• W4309305904 cites W2590406062 @default.
• W4309305904 cites W2752973507 @default.
• W4309305904 cites W2755381750 @default.
• W4309305904 cites W2789869568 @default.
• W4309305904 cites W2803606292 @default.
• W4309305904 cites W2807828215 @default.
• W4309305904 cites W2807852229 @default.
• W4309305904 cites W2885453373 @default.
• W4309305904 cites W2918708984 @default.
• W4309305904 cites W2937843015 @default.
• W4309305904 cites W2970350868 @default.
• W4309305904 cites W2982077551 @default.
• W4309305904 cites W2983042590 @default.
• W4309305904 cites W2994928858 @default.
• W4309305904 cites W2998445867 @default.
• W4309305904 cites W3017407215 @default.
• W4309305904 cites W3048853605 @default.
• W4309305904 cites W3138405449 @default.
• W4309305904 cites W3160303413 @default.
• W4309305904 cites W3195328787 @default.
• W4309305904 doi "https://doi.org/10.1182/bloodadvances.2022008548" @default.
• W4309305904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36399528" @default.
• W4309305904 hasPublicationYear "2023" @default.
• W4309305904 type Work @default.
• W4309305904 citedByCount "2" @default.
• W4309305904 countsByYear W43093059042023 @default.
• W4309305904 crossrefType "journal-article" @default.
• W4309305904 hasAuthorship W4309305904A5009302062 @default.
• W4309305904 hasAuthorship W4309305904A5010578315 @default.
• W4309305904 hasAuthorship W4309305904A5019389611 @default.
• W4309305904 hasAuthorship W4309305904A5037347309 @default.
• W4309305904 hasAuthorship W4309305904A5082926384 @default.
• W4309305904 hasBestOaLocation W43093059041 @default.
• W4309305904 hasConcept C126322002 @default.
• W4309305904 hasConcept C185592680 @default.
• W4309305904 hasConcept C190283241 @default.
• W4309305904 hasConcept C203014093 @default.
• W4309305904 hasConcept C2776694085 @default.
• W4309305904 hasConcept C2776755627 @default.
• W4309305904 hasConcept C2778119113 @default.
• W4309305904 hasConcept C2778461978 @default.
• W4309305904 hasConcept C2779429289 @default.
• W4309305904 hasConcept C2780007613 @default.
• W4309305904 hasConcept C2781107101 @default.
• W4309305904 hasConcept C2909962599 @default.
• W4309305904 hasConcept C502942594 @default.
• W4309305904 hasConcept C55493867 @default.
• W4309305904 hasConcept C71924100 @default.
• W4309305904 hasConcept C98274493 @default.
• W4309305904 hasConceptScore W4309305904C126322002 @default.
• W4309305904 hasConceptScore W4309305904C185592680 @default.
• W4309305904 hasConceptScore W4309305904C190283241 @default.
• W4309305904 hasConceptScore W4309305904C203014093 @default.
• W4309305904 hasConceptScore W4309305904C2776694085 @default.
• W4309305904 hasConceptScore W4309305904C2776755627 @default.
• W4309305904 hasConceptScore W4309305904C2778119113 @default.
• W4309305904 hasConceptScore W4309305904C2778461978 @default.

• next